肾小球CD68+细胞作为狼疮肾炎内皮细胞增生替代标志物的应用
研究纳入92例狼疮肾炎活检,评估肾小球CD68+细胞能否替代内皮细胞增生。肾小球CD68+细胞数与内皮细胞增生显著相关,单肾小球内CD68+细胞最大数阈值为7时,灵敏度88%、特异度67%。CD68+细胞与内皮细胞增生均与随访期肾功能相关,现行与新活动指数与临床结局的相关性相当。
要点
- 肾小球CD68+细胞数与狼疮肾炎内皮细胞增生显著相关。
- 单肾小球内CD68+细胞最大数阈值为7时,灵敏度88%、特异度67%。
- CD68+细胞替代内皮细胞增生后的新活动指数与现行活动指数和临床结局相关性相当。
核心结论
- 在狼疮肾炎中,CD68+细胞可作为内皮细胞增生的替代标志物。
研究设计与样本
- 共92例狼疮肾炎活检,采用CD68染色计数肾小球CD68+细胞,并评分内皮细胞增生和活动指数。
- 计算以CD68+细胞替代内皮细胞增生的新活动指数。
- 临床参数取自活检时、1年后和2年后。
主要发现
- 肾小球CD68+细胞数与内皮细胞增生显著相关。
- 单肾小球内CD68+细胞最大数阈值为7时,对内皮细胞增生的灵敏度为88%、特异度为67%。
- 内皮细胞增生和CD68+细胞均与随访期肾功能相关。
- 现行活动指数与新活动指数和临床结局的相关性相当。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Lupus nephritis (LN) class III or IV is strongly related to patient mortality and morbidity. The interobserver agreement of endocapillary hypercellularity by routine light microscopy, one of the most important lesions determining whether class III or IV is present, is moderate. In IgA nephropathy (IgAN), the presence of glomerular CD68+ cells was found to be a good surrogate marker for endocapillary hypercellularity. We investigated whether the presence of glomerular CD68+ cells could serve as a surrogate marker for endocapillary hypercellularity as well in LN. METHODS: A total of 92 LN biopsies were scored for the number of glomerular CD68+ cells using CD68 staining, including endocapillary hypercellularity and the activity index (AI). A new AI was calculated in which CD68+ cells replaced endocapillary hypercellularity. Clinical parameters were obtained from time of biopsy, 1 year after, and 2 years after. RESULTS: The number of glomerular CD68+ cells significantly correlated with endocapillary hypercellularity. A cutoff value of 7 for the maximum number of CD68+ cells within 1 glomerulus in a biopsy yielded a sensitivity of 88% and a specificity of 67% for the presence of endocapillary hypercellularity. Both endocapillary hypercellularity and CD68+ cells correlated with renal function during follow-up. The current and the new AI correlated equally well with the clinical outcome. CONCLUSION: In LN, CD68+ cells can be used as a surrogate marker for endocapillary hypercellularity.
引用
- Bos EMJ, Sangle SR, Wilhelmus S, et al. Use of Glomerular CD68+ Cells as a Surrogate Marker for Endocapillary Hypercellularity in Lupus Nephritis. Kidney Int Rep. 2022. PMID: 35497794. doi:10.1016/j.ekir.2021.12.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。